MedTrace Logo

Seroprevalence of SARS-CoV-2 in Unselected Surgical Patients: an Unicentric, Regional Study

NCT04839913 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 121

Last updated 2021-04-09

No results posted yet for this study

Summary

The investigator analyzed the data of the patients admitted to the surgical department during the period 1St September - 10Th December 2020 to estimate the seroprevalence of SARS-CoV-2 infection in the setting of a non-dedicated COVID-19 hospital and in a mild CoV-2 incidence area and to evaluate the difference of seroprevalence between Spring and Fall seasons in a cohort of patients undergoing surgery.

Conditions

  • SARS-CoV Infection
  • Seroprevalence
  • Covid19

Interventions

DIAGNOSTIC_TEST

Antibodies testing

Serologic test for both SARS-COV-2 IgG and IgM

Sponsors & Collaborators

  • University of Cagliari

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-09-01
Primary Completion
2020-12-10
Completion
2021-01-10

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04839913 on ClinicalTrials.gov